Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 35% Over the Past Week
Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 35% Over the Past Week
Key Insights
關鍵見解
- Given the large stake in the stock by institutions, Black Diamond Therapeutics' stock price might be vulnerable to their trading decisions
- The top 6 shareholders own 53% of the company
- Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company
- 鑑於機構持有該股的大量股份,Black Diamond Therapeutics的股價可能容易受到其交易決策的影響
- 前6名股東擁有公司53%的股份
- 使用分析師預測的數據以及所有權研究,可以更好地評估公司的未來表現
A look at the shareholders of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) can tell us which group is most powerful. With 58% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).
看看黑鑽療法公司(納斯達克股票代碼:BDTX)的股東可以告訴我們哪個集團最強大。機構擁有58%的股份,是公司的最大股份。換句話說,該集團面臨最大的上行潛力(或下行風險)。
Last week's 35% gain means that institutional investors were on the positive end of the spectrum even as the company has shown strong longer-term trends. The one-year return on investment is currently 32% and last week's gain would have been more than welcomed.
上週35%的漲幅意味着,儘管該公司表現出強勁的長期趨勢,但機構投資者仍處於積極的一端。目前,一年的投資回報率爲32%,上週的收益本來會非常受歡迎。
Let's take a closer look to see what the different types of shareholders can tell us about Black Diamond Therapeutics.
讓我們仔細看看不同類型的股東能告訴我們有關黑鑽療法的哪些信息。
![ownership-breakdown](https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20240201/0-5b3962833f36878889c78b258bb3c624-0-d52f59ee4ef5330cf4927f1129e014d6.png/big)
What Does The Institutional Ownership Tell Us About Black Diamond Therapeutics?
關於黑鑽療法,機構所有權告訴我們什麼?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
機構投資者通常將自己的回報與常見指數的回報進行比較。因此,他們通常會考慮收購相關基準指數中包含的大型公司。
Black Diamond Therapeutics already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Black Diamond Therapeutics' earnings history below. Of course, the future is what really matters.
Black Diamond Therapeutics已經在股票登記處設立了機構。事實上,他們擁有該公司可觀的股份。這表明專業投資者有一定的信譽。但是我們不能僅僅依靠這個事實,因爲機構有時會像所有人一樣進行不良投資。如果多家機構同時改變對股票的看法,你可能會看到股價快速下跌。因此,值得在下面查看黑鑽療法的收益記錄。當然,未來才是真正重要的。
![earnings-and-revenue-growth](https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20240201/0-5b3962833f36878889c78b258bb3c624-1-9bdb657cabd07553f2bd48b4db65c341.png/big)
Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. We note that hedge funds don't have a meaningful investment in Black Diamond Therapeutics. Bellevue Asset Management AG is currently the company's largest shareholder with 16% of shares outstanding. Versant Venture Management, LLC is the second largest shareholder owning 12% of common stock, and New Enterprise Associates, Inc. holds about 8.6% of the company stock.
由於機構投資者擁有已發行股票的一半以上,董事會可能必須注意他們的偏好。我們注意到,對沖基金沒有對黑鑽療法進行有意義的投資。貝爾維尤資產管理股份公司目前是該公司的最大股東,已發行股份爲16%。Versant Venture Management, LLC是第二大股東,擁有12%的普通股,而New Enterprise Associates, Inc.持有該公司約8.6%的股份。
We also observed that the top 6 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.
我們還觀察到,前六名股東佔股票登記冊的一半以上,少數規模較小的股東可以在一定程度上平衡大股東的利益。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
雖然研究公司的機構所有權數據是有意義的,但研究分析師的情緒以了解風向哪個方向吹來也是有意義的。有不少分析師報道了該股,因此你可以很容易地研究預測的增長。
Insider Ownership Of Black Diamond Therapeutics
黑鑽療法的內部人士所有權
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
不同國家對內部人士的定義可能略有不同,但董事會成員總是計算在內。公司管理層對董事會的回答,董事會應代表股東的利益。值得注意的是,有時高層管理人員自己也在董事會中。
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
當內部所有權表明領導層像公司的真正所有者一樣思考時,內部所有權是積極的。但是,高度的內部所有權也可以賦予公司內部的一小部分人巨大的權力。在某些情況下,這可能是負面的。
We can report that insiders do own shares in Black Diamond Therapeutics, Inc.. In their own names, insiders own US$5.1m worth of stock in the US$198m company. Some would say this shows alignment of interests between shareholders and the board, though we generally prefer to see bigger insider holdings. But it might be worth checking if those insiders have been selling.
我們可以報告說,內部人士確實擁有Black Diamond Therapeutics, Inc.的股份。內部人士以自己的名義擁有這家價值1.98億美元的公司價值510萬美元的股票。有人會說,這表明股東和董事會之間的利益一致,儘管我們通常更願意看到更多的內部持股。但是可能值得檢查一下這些內部人士是否一直在出售。
General Public Ownership
一般公有制
The general public-- including retail investors -- own 11% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
包括散戶投資者在內的公衆擁有該公司11%的股份,因此不容忽視。這種所有權規模雖然可觀,但如果決策與其他大股東不同步,可能不足以改變公司政策。
Private Equity Ownership
私募股權所有權
With an ownership of 28%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.
私募股權公司擁有28%的所有權,能夠在制定以價值創造爲重點的企業戰略方面發揮作用。有時我們會看到私募股權長期存在,但總的來說,它們的投資期限較短,而且顧名思義,對上市公司的投資並不多。一段時間後,他們可能會考慮出售資金並將其重新部署到其他地方。
Next Steps:
後續步驟:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Be aware that Black Diamond Therapeutics is showing 5 warning signs in our investment analysis , and 2 of those shouldn't be ignored...
我覺得看看究竟誰擁有一家公司非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。請注意,Black Diamond Therapeutics在我們的投資分析中顯示了5個警告信號,其中2個不容忽視...
If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.
如果你想了解分析師對未來增長的預測,千萬不要錯過這份關於分析師預測的免費報告。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。
譯文內容由第三人軟體翻譯。